Return to home page
Searching: Muskingum library catalog
We are currently experiencing delivery delays for items requested from other institutions while transitioning to a new statewide delivery service. Please contact your library with questions or advice about alternative resources. Thank you for your patience!

LEADER 00000cam  2200697Mi 4500 
001    1090496920 
003    OCoLC 
005    20190808061200.6 
006    m     o  d         
007    cr un|---aucuu 
008    190323s2019    sz      ob    001 0 eng d 
015    GBB990712|2bnb 
019    1091272871|a1103279595|a1105152380|a1105182194|a1106000560
       |a1110881432 
020    9783319977652|q(electronic bk.) 
020    3319977652|q(electronic bk.) 
020    3319977636 
020    9783319977638 
020    9783319977645|q(print) 
020    3319977644 
020    |z9783319977638 
024 7  10.1007/978-3-319-97765-2|2doi 
024 8  10.1007/978-3-319-97 
035    (OCoLC)1090496920|z(OCoLC)1091272871|z(OCoLC)1103279595
       |z(OCoLC)1105152380|z(OCoLC)1105182194|z(OCoLC)1106000560
       |z(OCoLC)1110881432 
037    com.springer.onix.9783319977652|bSpringer Nature 
040    EBLCP|beng|erda|epn|cEBLCP|dGW5XE|dUPM|dMERER|dOH1|dOCLCO
       |dVT2|dUKMGB|dDKU|dLQU|dYDX|dOCLCQ 
049    MAIN 
050  4 RC903|b.E53 2019 
060  4 WJ 300 
072  7 MJR|2bicssc 
072  7 MED055000|2bisacsh 
072  7 MJR|2thema 
082 04 616.6/1|223 
245 00 Endocrine disorders in kidney disease :|bdiagnosis and 
       treatment /|cConnie M. Rhee, Kamyar Kalantar-Zadeh, 
       Gregory A. Brent, editors. 
264  1 Cham, Switzerland :|bSpringer,|c[2019] 
300    1 online resource (346 pages) 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
347    text file|bPDF|2rda 
500    Triiodothyronine and Reverse Triiodothyronine in CKD 
504    Includes bibliographical references and index. 
505 0  Intro; Preface; Contents; Contributors; Part I: Diabetes, 
       Insulin Resistance, and the Metabolic Syndrome; 1: Insulin
       Resistance and the Metabolic Syndrome in Kidney Disease 
       (e.g., the Cardiorenal Metabolic Syndrome); Introduction; 
       Definition(s) of the Cardiorenal Metabolic Syndrome; 
       Epidemiology of the Cardiorenal Metabolic Syndrome; The 
       Cardiorenal Metabolic Syndrome and CKD; Insulin Resistance
       /Hyperinsulinemia; Inflammatory Cytokines; Inappropriate 
       Activation of the RAAS; Endothelial Dysfunction; 
       Conclusions and Perspectives; References; 2: Diabetic 
       Kidney Disease; Epidemiology 
505 8  PathophysiologyNatural History; Diagnosis; Prevention and 
       Treatment; Complications of Chronic Kidney Disease; 
       Conclusions; References; 3: Glucose Homeostasis and the 
       Burnt-Out Diabetes Phenomenon in Patients with Kidney 
       Disease; Introduction; Glucose Homeostasis in Kidney 
       Disease; Clearance of Insulin; Hypoglycemia Due to 
       Antidiabetic and Other Agents; Decreased Gluconeogenesis 
       in the Kidney; Insulin Secretion and Insulin Resistance; 
       Protein-Energy Wasting (PEW); Burnt-Out Diabetes 
       Phenomenon; Hemodialysis-Related Hypoglycemia and 
       Hyperglycemia; Hemodialysis-Induced Hypoglycemia 
505 8  Metabolic Effects Associated with Glucose-Free 
       DialysateHemodialysis-Associated Hyperglycemia; Insulin 
       Removal by Hemodialysis; Hemodialysis-Associated 
       Hyperglycemia Resembling the Somogyi Effect; References; 4
       : Glycemic Metrics and Targets in Kidney Disease; 
       Introduction; Glycemic Metrics and Their Role in Kidney 
       Disease; Glycated Hemoglobin (A1C); Glycated Albumin (GA);
       Fructosamine; 1,5-Anhydroglucitol (1,5-AG); Continuous 
       Glucose Monitoring (CGM); Glycemic Targets in Kidney 
       Disease; Conclusion; References; 5: Diabetic 
       Pharmacotherapies in Kidney Disease; Introduction; 
       Biguanides 
505 8  SulfonylureasMeglitinides; Glucagon-Like Peptide 1 
       Receptor Agonists (GLP-1 RAs); Dipeptidyl Peptidase IV 
       (DPP-4) Inhibitors; Thiazolidinediones; Sodium-Glucose Co-
       transporter 2 (SGLT2) Inhibitors; Alpha-Glucosidase 
       Inhibitors; Bromocriptine; Bile Acid Resins; Insulin; 
       Amylin Analog; Impact of Antihyperglycemic Agents on Renal
       Function; Conclusion; References; 6: Diabetes Mellitus and
       Renal Transplantation; Introduction; Changes in Glucose 
       Homeostasis During Peri-Kidney Transplantation; Changes in
       Glucose Homeostasis During the Immediate Posttransplant 
       Period 
505 8  New-Onset Diabetes After Kidney TransplantationClinical 
       and Economic Significance of NODAT; It Is Important to 
       Decrease the Incidence of NODAT; Timing of NODAT; 
       Pathogenesis of NODAT; Can Lifestyle Modification Be 
       Adapted for Prevention of NODAT?; Drugs for Preventing 
       NODAT; Conclusion; References; Part II: Thyroid 
       Dysfunction; 7: Evaluating Thyroid Function Tests in 
       Patients with Kidney Disease; Introduction; TSH 
       Measurement; TSH Levels in Chronic Kidney Disease 
       Patients; Measuring Free Thyroxine and Free 
       Triiodothyronine; Thyroxine (T4) Changes with CKD 
520    This comprehensive book examines the complex interplay 
       between endocrine and kidney disorders, and how this inter
       -relationship impacts patients with chronic kidney 
       disease. Authored by experts in areas of endocrinology and
       nephrology, chapters cover a variety of topics, including 
       diabetes, metabolic syndrome, thyroid dysfunction, gonadal
       disorders, dyslipidemia, mineral bone disorders, obesity, 
       and pituitary disorders. These comorbidities are 
       thoroughly examined and provide the clinician, researcher,
       and trainee with a greater understanding of the impact of 
       endocrine disorders on kidney disease patients, the 
       ability to identify persistent gaps in knowledge for 
       future investigation, and move closer towards the goal of 
       improving the health and survival of the chronic kidney 
       disease population. 
588 0  Print version record. 
650  0 Kidneys|xDiseases|0http://id.loc.gov/authorities/subjects/
       sh85072261|xEndocrine aspects.|0http://id.loc.gov/
       authorities/subjects/sh00005622 
650  2 Kidney Diseases.|0https://id.nlm.nih.gov/mesh/D007674 
650  2 Endocrine System Diseases.|0https://id.nlm.nih.gov/mesh/
       D004700 
655  4 Electronic books. 
700 1  Rhee, Connie M.,|0http://id.loc.gov/authorities/names/
       n2020180002|eeditor. 
700 1  Kalantar-Zadeh, Kamyar,|0http://id.loc.gov/authorities/
       names/n2013181337|eeditor. 
700 1  Brent, Gregory A.,|0http://id.loc.gov/authorities/names/
       nb2010011445|eeditor. 
776 08 |iPrint version:|aRhee, Connie M.|tEndocrine Disorders in 
       Kidney Disease : Diagnosis and Treatment.|dCham : Springer,
       2019|z9783319977638|w(OCoLC)1042405634. 
990    SpringerLink|bSpringer English/International eBooks 2019 -
       Full Set|c2019-08-07|yNew collection 
       springerlink.ebooks2019|5OH1 
LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team